Evidence map›Paper›PMID 31963315›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Metabolomics Elucidates Dose-Dependent Molecular Beneficial Effects of Hesperidin Supplementation in Rats Fed an Obesogenic Diet.

Maria Guirro, Andreu Gual-Grau, Albert Gibert-Ramos, Juan Maria Alcaide-Hidalgo, Núria Canela, Lluís Arola, Jordi Mayneris-Perxachs

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Jeju Citrus (International journal of molecular sciences · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Maria GuirroEurecat, Centre Tecnològic de Catalunya, Technological Unit of Omics Sciences, 43204 Reus, Spain.
Andreu Gual-GrauNutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili. Marcel.lí Domingo, 1, 43007 Tarragona, Spain.
Albert Gibert-RamosNutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili. Marcel.lí Domingo, 1, 43007 Tarragona, Spain.ORCID 0000-0002-5987-1164
Juan Maria Alcaide-HidalgoEurecat, Centre Tecnològic de Catalunya, Technological Unit of Nutrition and Health, 43204 Reus, Spain.ORCID 0000-0001-5705-7807
Núria CanelaEurecat, Centre Tecnològic de Catalunya, Technological Unit of Omics Sciences, 43204 Reus, Spain.ORCID 0000-0003-0261-2396
Lluís ArolaEurecat, Centre Tecnològic de Catalunya, Technological Unit of Omics Sciences, 43204 Reus, Spain.ORCID 0000-0003-2767-1974
Jordi Mayneris-PerxachsEurecat, Centre Tecnològic de Catalunya, Technological Unit of Omics Sciences, 43204 Reus, Spain.ORCID 0000-0003-3788-3815
Universitat Rovira i Virgili · ESTechnological Center of Nutrition and Health · ESInstituto de Salud Carlos III · ES

Funding

Agència per a la Competitivitat de l'Empresa TECSPR14-2-0001
6 · The paper itself

Abstract

Metabolic syndrome (MetS) is a global epidemic concern. Polyphenols are proposed as good candidates for its prevention, although their mechanisms are not fully understood. The gut microbiota seems to play a key role in polyphenol beneficial effects. Here, we assessed the effects of the citrus polyphenol hesperidin combining an untargeted metabolomics approach, which has an inherent potential to elucidate the host-microbiome interplay, with extensive anthropometric and biochemical characterizations and integrating metabolomics results with our previous 16S rRNA bacterial sequencing data. The rats were fed either a standard or an obesogenic cafeteria diet (CAF) for 17 weeks. After nine weeks, rats were supplemented with vehicle; low- (H1), or high- (H2) hesperidin doses. CAF animals developed MetS features. Hesperidin supplementation in CAF rats decreased the total cholesterol, LDL-C, and free fatty acids. The highest hesperidin dose also ameliorated blood pressure, insulin sensitivity, and decreased markers of arterial stiffness and inflammation. Metabolomics revealed an improvement of the lipidomic profile, decreases in circulating amino acids, and lower excretions of inflammation- and oxidative stress-related metabolites.

Indexed as

cafeteria dietcitrus flavanonesgut microbiomehesperidinmetabolic phenotypingmetabolic syndromemetabolomicspolyphenols

Identifiers

PMID31963315
PMCPMC7023145
OpenAlexW2999935401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.